About Mepro
Mepro is a Healthcare company based in Mumbai (India) founded in 1982. Manufacturing and exporting of pharmaceuticals is conducted by Mepro globally. The company has 543 employees. Its Indian entity Mepro Pharmaceuticals Private Limited reported revenue of ₹356 Cr. Mepro offers products and services including Medicines and Generic Drugs. Its focus areas include Research and Development, Drug Innovation, Formulation and Export and Pharmaceuticals.
Company details
Mepro is recognized as a pharmaceutical entity that formulates and exports medicines to over 40 countries, with state-of-the-art facilities in multiple Indian cities ensuring quality through technology-driven processes. Commitment is shown to innovation, including development of novel drug delivery systems and adherence to regulatory standards like EU GMP. Corporate social responsibility efforts are evident in partnerships addressing neglected diseases and supporting global health initiatives, such as treatments for Soil Transmitted Helminths and aid for refugees. A focus is placed on research and employee empowerment to advance affordable healthcare solutions.
- Headquarters Mumbai, India
- Employees 543
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Social Facebook
- Legal Name Mepro Pharmaceuticals Pvt. Ltd
- Date of Incorporation 31 Aug, 1982
- Jurisdiction Surendra Nagar, Gujarat, India
- Annual Revenue₹356 Cr
FY 2025 · +20% YoY
- Net Profit₹35.11 Cr
FY 2025 · 10% margin
- EBITDA₹61.89 Cr
FY 2025 · 17% margin
- Employee Count543
Associated legal entities of Mepro
Mepro operates through Mepro Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Mepro Pharmaceuticals Private Limited CIN U24231GJ1982PTC005451 | Active | 31 Aug 1982 | Surendranagar, Gujarat | ₹356 Cr | 543 | 5 | View details |
Products & Services of Mepro
Mepro offers a comprehensive portfolio of products and services, including Medicines and Generic Drugs.
Medicines are formulated by Mepro for global export, covering a range of formulations including tablets and sterile products.
Generic drugs are developed and supplied by Mepro, targeting markets in Europe, the US, and other regions with adherence to international standards.
Board of directors of Mepro Pharmaceuticals Private Limited (Mepro)
Mepro Pharmaceuticals Private Limited is the primary company behind Mepro. The board of Mepro Pharmaceuticals Private Limited currently have 5 directors; the longest-serving is Bharatkumar Chabildas Shah, appointed in 1982. 9 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Bharatkumar Chabildas Shah DIN 00867909 | Director | 31 Aug 1982 | 44 yrs 1 mo | Mepro Pharmaceuticals Private Limited |
| Suresh Chhabildas Shah DIN 00477470 | Director | 31 Aug 1982 | 44 yrs 1 mo | Mepro Pharmaceuticals Private Limited |
| Vijay Chhabildas Shah DIN 00453308 | Whole-time director | 31 Aug 1982 | 44 yrs 1 mo | Mepro Pharmaceuticals Private Limited |
| Rajesh Sumanlal Shah DIN 00821466 | Director | 30 Sep 1987 | 39 yrs | Mepro Pharmaceuticals Private Limited |
| Prakash Navinchandra Shah DIN 00641718 | Director | 17 Jul 2004 | 22 yrs 3 mo | Mepro Pharmaceuticals Private Limited |
Financials of Mepro
Figures of Mepro Pharmaceuticals Private Limited, the primary company behind Mepro, for FY 2025. Revenue was ₹356 Cr (+20% year on year). Net profit was ₹35.11 Cr (10% margin). EBITDA was ₹61.89 Cr (17% margin). Revenue has grown at a compounded annual rate of +19% over three years and +17% over five years.
- ₹356 CrRevenue · FY 2025 · +20% YoY
- ₹35.11 CrNet profit · 10% margin
- ₹61.89 CrEBITDA · 17% margin
- ₹5.35 CrPaid-up capital
- 543Employees (provident fund records)
- +19%Revenue CAGR, 3 years
- +17%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Mepro Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Mepro
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Mepro
Websites that share an audience with Mepro (mepro.in).
Websites whose visitors overlap most with Mepro. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| kesarpharma.com | 87% | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Mepro
Mepro was founded in 1982.
Mepro is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Mepro has 543 employees.
The primary company behind Mepro, Mepro Pharmaceuticals Private Limited, reported revenue of ₹356 Cr for FY 2025, up 20% year on year.
Mepro is recognized as a pharmaceutical entity that formulates and exports medicines to over 40 countries, with state-of-the-art facilities in multiple Indian cities ensuring quality through technology-driven processes. Commitment is shown to innovation, including development of novel drug delivery systems and adherence to regulatory standards like EU GMP. Corporate social responsibility efforts are evident in partnerships addressing neglected diseases and supporting global health initiatives, such as treatments for Soil Transmitted Helminths and aid for refugees. A focus is placed on research and employee empowerment to advance affordable healthcare solutions.
Mepro offers Medicines and Generic Drugs.
Mepro operates through Mepro Pharmaceuticals Private Limited.
The legal entities of Mepro currently have 5 directors, including Prakash Navinchandra Shah, Bharatkumar Chabildas Shah, Suresh Chhabildas Shah and others.